8-K

Company

Xenon Pharmaceuticals Inc.

Filed

November 7, 2022

Period of Report

November 7, 2022

Accession Number

0000950170-22-022588

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →